A real-world study found Erleada reduced the risk of death compared with Nubeqa in patients with metastatic ...

NHS patients will be told their real-time cancer risk with the help of gadgets such as smartwatches. Everyone will be able to ...

Cleveland Clinic researchers have found that nearly two-thirds of patients with HER2-positive metastatic breast cancer did not receive the guideline-recommended standard of care treatment between 2015 ...

An international research team with strong participation from DTU has developed a new biotechnological platform that makes it possible to test and understand advanced cancer treatments much faster and ...

A new study from researchers in Spain discovered that triple therapy could entirely eliminate pancreatic cancer in mice.

Inova Schar Cancer announced last week the launch of Adaptive Online Radiotherapy, a significant technological advancement in cancer treatment that allows doctors to adjust a patient’s radiation plan ...

NEW YORK (September 9, 2025)—Voices of Oncology: Fostering a Collaborative Community of Experts to Accelerate Cancer Cures by Kirk V. Shepard, M.D., and Ramin Farhood, PharmD, M.B.A., brings together ...

Understanding these microscopic messengers could change the fight against metastasis. Preventing cancer from spreading ...

HER2 and ABCC1 are identified as significant transcriptomic predictors of overall survival in patients treated with T-DXd. A large-scale analysis reveals novel predictors of survival and resistance ...

Blood Cancer UK, Lymphoma Action and stem cell charity Anthony Nolan have formally appealed against the decision.

New research shows lymph nodes aren’t just cancer bystanders, they’re the command centers fueling immune attacks. Surgically removing them along with tumors may weaken treatment, while preserving them ...

Cancer care today is more advanced and patient-centric than ever before, with improved survival rates, personalised therapies ...